Improving Membrane Permeation in the Beyond Rule-of-Five Space by Using Prodrugs to Mask Hydrogen Bond Donors
- 6 July 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 15 (8) , 2070-2078
Abstract
A wide range of drug targets can be effectively modulated by peptides and macrocycles. Unfortunately, the size and polarity of these compounds prevents them from crossing the cell membrane to reach target sites in the cell cytosol. As such, these compounds do not conform to standard measures of drug-likeness and exist in beyond the rule-of-five space. In this work, we investigate whether prodrug moieties that mask hydrogen bond donors can be applied in the beyond rule-of-five domain to improve the permeation of macrocyclic compounds. Using a cyclic peptide model, we show that masking hydrogen bond donors in the natural polar amino acid residues (His, Ser, Gln, Asn, Glu, Asp, Lys, and Arg) imparts membrane permeability to the otherwise impermeable parent molecules, even though the addition of the masking group increases the overall compound molecular weight and the number of hydrogen bond acceptors. We demonstrate this strategy in PAMPA and Caco2 membrane permeability assays and show that masking with groups that reduce the number of hydrogen-bond donors at the cost of additional mass and hydrogen bond acceptors, a donor–acceptor swap, is effective.Keywords
Funding Information
- National Health and Medical Research Council (1099428)
This publication has 58 references indexed in Scilit:
- Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challengesBioorganic & Medicinal Chemistry Letters, 2019
- Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining ChallengesJournal of the American Chemical Society, 2019
- Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 spaceCurrent Opinion in Chemical Biology, 2018
- Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound CollectionJournal of Medicinal Chemistry, 2017
- Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targetsCurrent Opinion in Chemical Biology, 2017
- Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical CandidatesChemistry & Biology, 2014
- Lead optimization in the nondrug-like spaceDrug Discovery Today, 2011
- Drug discovery beyond the ‘rule-of-five’Current Opinion in Biotechnology, 2007
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997